drugset / Trial / NCT02301208
Weekly Cisplatin or Nedaplatin Concurrent With Intensity-modulated Radiation Therapy in Nasopharyngeal Carcinoma
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a randomized Phase III study to evaluate efficancy of weekly cisplatin or nedaplatin concurrent with Intensity-modulated radiation therapy in Nasopharyngeal Carcinoma (NPC).
Timeline
- Start
- 2014-12
- Primary completion
- 2016-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cisplatin | Other / unclassified | 20 mg/m2 | — |
| Comparator | Cisplatin | Other / unclassified | 30 mg/m2 | — |
| Subject | Nedaplatin | Small molecule | 20 mg/m2 | — |
| Subject | Nedaplatin | Small molecule | 30 mg/m2 | — |